comparemela.com

Latest Breaking News On - Advanced recurrent endometrial cancer - Page 1 : comparemela.com

Dr Eskander on Pembrolizumab Plus Chemo in Advanced/Recurrent Endometrial Cancer

Ramez N. Eskander, MD, discusses overall survival data for pembrolizumab plus chemotherapy in advanced/recurrent endometrial cancer.

United statesSan diegoRamezn eskanderReproductive sciencesSan diego healthUniversity of californiaMoores cancer centerAdvanced recurrent endometrial cancerPembrolizumab plus chemotherapy

The Future of Clinical Care for Patients With Advanced Endometrial Cancer

Closing their conversation, Ramez Eskander, MD, and Krishnansu Tewari, MD, share how they envision the future treatment landscape for patients with advanced endometrial cancer.

Ramez eskanderKrishnansu tewariTreatment approachTreatment optionsAdvanced endometrial cancerClinical carePatients with advanced endometrialEndometrial cancerEndometrial carcinomaAdvanced endometrial carcinomaFirst line treatments endometrial cancerSecond line treatments endometrial cancerRecurrent endometrial cancerAdvanced recurrent endometrial cancer

Emerging Targeted Treatment Options for Patients With Advanced Endometrial Cancer

Key opinion leaders discuss targeted treatment regimens for advanced or recurrent endometrial cancer that are currently under development.

Treatment approachTreatment optionsAdvanced endometrial cancerTargeted treatment optionsPatients with advanced endometrialEndometrial cancerEndometrial carcinomaAdvanced endometrial carcinomaFirst line treatments endometrial cancerSecond line treatments endometrial cancerRecurrent endometrial cancerAdvanced recurrent endometrial cancer

Patient Profile Presentation: A 68-Year-Old Woman With Recurrent Endometrial Cancer

Krishnansu Tewari, MD, presents the profile of a 68-year-old postmenopausal woman with recurrent endometrial cancer for discussion.

Krishnansu tewariTreatment approachTreatment optionsAdvanced endometrial cancerProfile presentationYear old woman with recurrent endometrialEndometrial cancerEndometrial carcinomaAdvanced endometrial carcinomaFirst line treatments endometrial cancerSecond line treatments endometrial cancerRecurrent endometrial cancerAdvanced recurrent endometrial cancer

Recent Data on IO-Based Combination Regimens for First-line Treatment of Advanced Endometrial Carcinoma

Krishnansu Tewari, MD, reviews emerging data from two studies investigating immunotherapy-based combination regimens for the first-line treatment of advanced endometrial cancer.

Krishnansu tewariTreatment approachTreatment optionsAdvanced endometrial cancerBased combination regimensFirst line treatmentAdvanced endometrialEndometrial cancerEndometrial carcinomaAdvanced endometrial carcinomaFirst line treatments endometrial cancerSecond line treatments endometrial cancerRecurrent endometrial cancerAdvanced recurrent endometrial cancer

vimarsana © 2020. All Rights Reserved.